2022 [cited 2022 Aug 22];120007
A Trustpilot listing shows a TrustScore around 3.1/5 on a small number of reviews as of July 2026 - check the current count directly before enrolling
Using the nominal group technique: how to analyse across multiple groups
In one study, exogenous administration of combined GLP-1R/Y2-R agonists partially mimicked the positive effects of bariatric surgery but did not lead to the anticipated overall metabolic improvements 10 suggesting other pathways are also involved
La galena coment que diversos estudios revelaron que la semaglutida solo bajaba la glicemia en pacientes diabticos y que el riesgo de hipoglucin (bajn de azcar) era muy mnimo en pacientes no diabticos , por tanto, se autoriz la comercializacin de otro GLP, la liraglutida ( Saxenda ) que est comercializado para perder peso y est aprobado para perder peso
SS attended scientific advisory committee meetings for AstraZeneca, Atara, Bristol-Myers-Squibb, Merck, Novartis, Panalgo, Pfizer, and Seqirus and received speaking fees from Boehringer-Ingelheim and Novartis
